Dr. Steven Rosenberg is chief of surgery with the National Cancer Institute. Originally from New York City, Dr. Rosenberg received his bachelor's and medical degrees from Johns Hopkins University in Baltimore, and his Ph.D. in biophysics from Harvard.
After completing his surgical internship and residency at Peter Bent Brigham Hospital in Boston, he came to NIH in 1974 as chief of surgery.
Dr. Rosenberg has pioneered the development of effective immunotherapies for selected patients with advanced cancers. He was the first to insert foreign genes into humans, paving the way for studies of gene therapy for cancer. He has authored over 700 articles and two dozen books on various aspects of cancer research.
Dr. Mark Gladwin earned both his bachelor's degree in biology and his medical degree at the University of Miami. He completed an internship, residency, and chief residency in internal medicine at the Oregon Health Sciences University, in Portland.
Dr. Gladwin first came to the CC in 1995 as a critical care fellow. He then did a pulmonary-critical care fellowship at the University of Washington in Seattle, before returning this year as a senior research fellow with Critical Care.
Dr. Gladwin's research focuses on the use of nitric oxide in sickle cell anemia. He is working on the upkeep and breeding of a sickle cell transgenic mouse colony, nitric oxide donor experiments, and the translation of animal experiments to the clinical arena.
Questions about the Clinical Center or CC grand rounds? OCCC@nih.gov
Or call: (301) 496-2563
National Institutes of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland 20892. Last modified 9/99